Cornell University

ARMOUR Residential REIT, Inc. Names Sergey Losyev and Desmond Macauley as Co-Chief Investment Officers

Retrieved on: 
Monday, March 18, 2024
NatWest Markets, CIO, Risk management, ARR, University, Cornell University, Merrill (company), DWS Group, MBA, MBS, CFA, Agency, Strategy

VERO BEACH, Florida, March 18, 2024 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR PRC) (“ARMOUR” or the “Company”) today announced the promotions of Sergey Losyev and Desmond Macauley to Co-Chief Investment Officers (CIO), effective March 18, 2024.

Key Points: 
  • VERO BEACH, Florida, March 18, 2024 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR PRC) (“ARMOUR” or the “Company”) today announced the promotions of Sergey Losyev and Desmond Macauley to Co-Chief Investment Officers (CIO), effective March 18, 2024.
  • Mr. Losyev and Mr. Macauley succeed Mark Gruber, who stepped down.
  • Mr. Losyev joined ARMOUR in 2016 and has served as Deputy Chief Investment Officer since January 2020.
  • Mr. Macauley has served as the Director of Investment Strategies at ARMOUR since May 2013.

NCLA Demands Trial to Prove Ex-Professor’s Case Against Cornell’s Title IX Kangaroo Court

Retrieved on: 
Thursday, March 14, 2024
Pressure, University, Bias, District court, Cornell University, Faculty, Wind, Title, Title IX, DOE, Collegiality, NCLA

Dr. Vengalattore was a tenure-track Cornell University physics professor when a former graduate student’s false 2014 sexual misconduct allegation launched an utterly due-process deficient Title IX investigation that ruined his promising career.

Key Points: 
  • Dr. Vengalattore was a tenure-track Cornell University physics professor when a former graduate student’s false 2014 sexual misconduct allegation launched an utterly due-process deficient Title IX investigation that ruined his promising career.
  • The district court initially dismissed his Title IX claims, concluding the Title IX cause of action did not extend to faculty.
  • Courts have previously found that universities that followed the DOE guidance eviscerating commonsense procedural protections violated rather than complied with Title IX.
  • In Dr. Vengalattore’s case, Cornell changed or ignored multiple policies and procedures to placate DOE, ironically leading to the university’s violating Title IX rather than complying with it.

Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit

Retrieved on: 
Thursday, March 14, 2024
CELU, Cell, Tissue, Research, Sarcopenia, Cornell University, Cancer, Biology, Pulse, Regenerative medicine, Immunity, Placenta, Singularity Group, Immunosenescence, Movement, Autoimmunity, Ageing, Medicine

Dr. Hariri’s presentation, titled “The Cell Therapy Basis for Longevity,” will discuss the potential for using cellular therapeutics to address the biological ravages of aging by combating immunosenescence, sarcopenia and degenerative diseases.

Key Points: 
  • Dr. Hariri’s presentation, titled “The Cell Therapy Basis for Longevity,” will discuss the potential for using cellular therapeutics to address the biological ravages of aging by combating immunosenescence, sarcopenia and degenerative diseases.
  • Dr. Hariri has led the effort to harness the unique biology of placental-derived cells in a range of clinical indications, including cancer, autoimmune and degenerative diseases.
  • “Dr.
  • This work puts Dr. Hariri at the forefront of the longevity movement, with his finger on the pulse of the ever-changing landscape.”
    The ABUNDANCE Summit will occur in Los Angeles, Calif., from March 17 through 21, 2024.

Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya

Retrieved on: 
Tuesday, March 12, 2024
Food, General Electric, IGI, Organization, OMEGA, Business, Executive, Cornell University, Boy, Sale, Rutgers University, Clinical trial, Therapy, DRL, Fortune 500

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the appointment of Dr. Jonathan Rich to its board of directors and Hem Pandya as Executive Chairman of the board of directors.

Key Points: 
  • NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the appointment of Dr. Jonathan Rich to its board of directors and Hem Pandya as Executive Chairman of the board of directors.
  • “We are delighted to welcome Hem Pandya as the Executive Chairperson of Intrommune’s Board of Directors and Dr. Jon Rich as a board member,” said Michael Nelson, CEO, Intrommune Therapeutics.
  • I look forward to supporting the development of Intrommune’s demonstrated safe and convenient food allergy therapies,” said Hem Pandya.
  • Along with serving as Executive Chairman for Intrommune, Mr. Pandya currently serves on the Board of Directors for Exchange Health, LLC, Senores Pharmaceuticals and on the Board of Advisors for Anodyne Nanotech, Inc.

Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors

Retrieved on: 
Tuesday, March 12, 2024
Harvard College, Health, Internal medicine, Public health, Disease, Atossa, Oncology, Patient, Cornell University, Weill Cornell Medical Center, Woman, Helsinki University Central Hospital, Clinical trial, Therapy, Breast cancer, Hematology, Weill Cornell Medicine, Pharmaceutical industry

Dr. Cigler is a medical oncologist and clinical investigator at the Weill Cornell Breast Center in New York City.

Key Points: 
  • Dr. Cigler is a medical oncologist and clinical investigator at the Weill Cornell Breast Center in New York City.
  • “We are pleased to welcome Dr. Cigler to our board of directors,” said Steven Quay, M.D., Ph.D., Atossa’s President and Chief Executive Officer.
  • “Tessa works daily with breast cancer patients and knows firsthand the critical need for more effective and tolerable treatment options.
  • While progress has been made over the past decade, breast cancer remains a deadly disease for hundreds of thousands of women globally each year.

Vineyard Wind Named Climate Change Project of the Year by Environmental Business Council of New England

Retrieved on: 
Thursday, April 4, 2024
Other Energy, Utilities, Environment, Sustainability, Alternative Energy, Green Technology, Energy, Electricity, Wind, PLA, Climate change, Vineyard Wind, Government, EBC, Partnership, CIP, Cornell University, Climate, Ruth, Carbon, Lawyer, City Winery, Copenhagen Infrastructure Partners, AGR, Silman, Commonwealth, Vineyard, Renewable energy

The award, which was established in January 2020, recognizes a project or endeavor which demonstrates leadership in climate change.

Key Points: 
  • The award, which was established in January 2020, recognizes a project or endeavor which demonstrates leadership in climate change.
  • “We are honored and grateful to receive this important recognition for our Vineyard Wind 1 project, and thank the Environmental Business Council for their partnership and support as we work together to take urgent action on climate change,” said Avangrid CEO Pedro Azagra.
  • Vineyard Wind 1 is the first large-scale offshore wind project in the United States.
  • In July 2021, Vineyard Wind signed the first Project Labor Agreement for an offshore wind project in the United States, which outlined the creation of 500 union jobs through the project.

Expel Elevates Former VP, Cat Starkey, to Chief Technology Officer

Retrieved on: 
Tuesday, April 2, 2024
Data Management, Security, Technology, Software, Networks, Artificial Intelligence, Internet, Human, Cornell University, Architecture, Blackboard, Software as a service, MDR, Engineering, CA Technologies, Management

Expel , the leading managed detection and response (MDR) provider, today announced the promotion of Cat Starkey to Chief Technology Officer (CTO).

Key Points: 
  • Expel , the leading managed detection and response (MDR) provider, today announced the promotion of Cat Starkey to Chief Technology Officer (CTO).
  • “I’m thrilled for the opportunity to spearhead Expel’s engineering strategy and push the limits of MDR technology,” said Starkey.
  • She continuously challenges the status quo, and works to affect positive change for the good of her team and the technology it’s engineering.
  • “Cat has the distinct ability to pioneer innovation in ways that differentiate our offerings, while improving efficiencies that contribute to our financial success—giving Expel excellent engineering at scale,” said Dave Merkel, CEO and co-founder, Expel.

Gatewood Capital Partners Announces Promotions

Retrieved on: 
Monday, April 1, 2024
Asset Management, Professional Services, Finance, Comparative, Certified Public Accountant, Culture, LLB, Growth, Computing, Cornell University, Duff, Duff & Phelps, Information science, EY, Mizuho Bank, Master of Science, Investment, Analyst, JPMorgan Chase, Blackstone Inc., Marketing

Gatewood Capital Partners LLC (“Gatewood”), a premier private equity firm focused on seeding and anchoring emerging managers, today announced promotions and expanded roles of its team.

Key Points: 
  • Gatewood Capital Partners LLC (“Gatewood”), a premier private equity firm focused on seeding and anchoring emerging managers, today announced promotions and expanded roles of its team.
  • Mr. Zassman focuses on investment origination, due diligence and portfolio management at Gatewood.
  • Before joining Gatewood in 2021, Mr. Zassman held several positions at Blackstone Inc., most recently as a member of the Blackstone Strategic Capital Group’s investment team, focused on GP stakes investments.
  • Amir Aviv, Managing Partner of Gatewood, added, “These promotions and increased responsibilities reflect their contributions and positive impact at the firm and with our portfolio investments.

NTT Research PHI Lab Scientists Achieve Quantum Control of Excitons in 2D Semiconductors

Retrieved on: 
Tuesday, March 26, 2024
Semiconductor, Technology, Nanotechnology, Telecommunications, Other Science, Research, Science, ETH Zurich, Photon, Physics, University of Notre Dame, Logic, 2D, CMOS, Quantum, PHI, MIT, Cornell University, Ames Research Center, Swinburne University of Technology, Light, University, Nature, Nobel Prize, Architecture, Silicon, NASA, Harvard University, NTT, Stanford University, CIM, Ising, Quantum dot, Engineering, Microscope

NTT Research, Inc. , a division of NTT (TYO:9432), today announced that scientists from its Physics & Informatics (PHI) Lab have achieved quantum control of exciton wavefunctions in two-dimensional (2D) semiconductors.

Key Points: 
  • NTT Research, Inc. , a division of NTT (TYO:9432), today announced that scientists from its Physics & Informatics (PHI) Lab have achieved quantum control of exciton wavefunctions in two-dimensional (2D) semiconductors.
  • However, achieving fine control over their quantum mechanical state has been plagued with scalability issues due to limitations in existing fabrication techniques.
  • In particular, the control over position and energy of quantum dots has been a major hindrance to scaling up towards quantum applications.
  • The PHI Lab has also entered a joint research agreement with the NASA Ames Research Center in Silicon Valley.

Mitchell Silberberg & Knupp Names First Director of DEI and Talent Development

Retrieved on: 
Tuesday, March 26, 2024
Professional Services, Legal, DEI (Diversity, Equity and Inclusion), Culture, Silberberg, Partnership, Rutgers Law School, Cornell University, Left–right political spectrum, Diversity, Talent, LLP, Equity, Law, Lawyer, Fortune 500, Multimedia, MSK, Georgian Court University, Workplace, Training and development, DEI

Mitchell Silberberg & Knupp LLP is pleased to announce that the firm has appointed Iveliz Crespo as its first Director of DEI and Talent Development, reaffirming its dedication to advancing diversity, equity, and inclusion (DEI) within the legal profession.

Key Points: 
  • Mitchell Silberberg & Knupp LLP is pleased to announce that the firm has appointed Iveliz Crespo as its first Director of DEI and Talent Development, reaffirming its dedication to advancing diversity, equity, and inclusion (DEI) within the legal profession.
  • View the full release here: https://www.businesswire.com/news/home/20240326334961/en/
    Iveliz Crespo, Director of Diversity and Talent Development at Mitchell Silberberg & Knupp LLP (Photo: Business Wire)
    “We are thrilled to welcome Iveliz to Mitchell Silberberg & Knupp as our first Director of DEI and Talent Development,” said Greg Hessinger, Chair of MSK.
  • Crespo will oversee the development and implementation of comprehensive DEI strategies, aimed at attracting, retaining, and advancing diverse talent within MSK.
  • “Mitchell Silberberg & Knupp has already displayed an impressive commitment to DEI both within the firm and to its clients,” said Crespo.